000299573 001__ 299573
000299573 005__ 20250311112152.0
000299573 0247_ $$2doi$$a10.21037/tau-24-489
000299573 0247_ $$2ISSN$$a2223-4683
000299573 0247_ $$2ISSN$$a2223-4691
000299573 037__ $$aDKFZ-2025-00514
000299573 082__ $$a610
000299573 1001_ $$0P:(DE-He78)4eba3fd5702e3a245f0b304e53203b2a$$aMai, Lixin$$b0$$eFirst author$$udkfz
000299573 245__ $$aClinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?
000299573 260__ $$aHongkong$$bAME Publishing Company$$c2025
000299573 3367_ $$2DRIVER$$aarticle
000299573 3367_ $$2DataCite$$aOutput Types/Journal article
000299573 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1741610823_15764
000299573 3367_ $$2BibTeX$$aARTICLE
000299573 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000299573 3367_ $$00$$2EndNote$$aJournal Article
000299573 500__ $$a#EA:E055#
000299573 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000299573 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000299573 7001_ $$aLiu, Ruiqi$$b1
000299573 7001_ $$aZhang, Xinyue$$b2
000299573 7001_ $$aPan, Qiwen$$b3
000299573 7001_ $$aCai, Lingling$$b4
000299573 7001_ $$aCao, Wufei$$b5
000299573 7001_ $$aLi, Yonghong$$b6
000299573 7001_ $$aZhou, Fangjian$$b7
000299573 7001_ $$aGao, Jianming$$b8
000299573 7001_ $$aLiu, Yang$$b9
000299573 7001_ $$aHe, Liru$$b10
000299573 773__ $$0PERI:(DE-600)2851630-8$$a10.21037/tau-24-489$$gVol. 14, no. 2, p. 228 - 239$$n2$$p228 - 239$$tTranslational andrology and urology$$v14$$x2223-4683$$y2025
000299573 909CO $$ooai:inrepo02.dkfz.de:299573$$pVDB
000299573 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4eba3fd5702e3a245f0b304e53203b2a$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000299573 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000299573 9141_ $$y2025
000299573 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000299573 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000299573 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000299573 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-20
000299573 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-20
000299573 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000299573 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000299573 9200_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x0
000299573 980__ $$ajournal
000299573 980__ $$aVDB
000299573 980__ $$aI:(DE-He78)E055-20160331
000299573 980__ $$aUNRESTRICTED